Inhibición de la progresión del daño estructural articular con upadacitinib en arthritis reumatoide: resultados de un año del programa de fase 3 SELECT
Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab861
Keywords:
Publications
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.